Elite Pharmaceuticals Inc /NV/ SEC filings ELTP
Elite Pharmaceuticals Inc /NV/ has 1,000 filings in SEC EDGAR's recent list, going back to Apr 5, 2005. Its latest annual report, Form 10-K, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Jun 29, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Jun 30, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Jul 1, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Jul 31, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Jun 29, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Jun 29, 2022 | Mar 31, 2022 |
| 10-K/A | Amended annual report | Jun 22, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Jun 14, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Jun 29, 2020 | Mar 31, 2020 |
| 10-K | Annual report | Jun 21, 2019 | Mar 31, 2019 |
| 10-K | Annual report | Jun 14, 2018 | Mar 31, 2018 |
| 10-K | Annual report | Jun 14, 2017 | Mar 31, 2017 |
| 10-K/A | Amended annual report | Nov 17, 2016 | Mar 31, 2011 |
| 10-K/A | Amended annual report | Jul 11, 2016 | Mar 31, 2015 |
| 10-K | Annual report | Jun 15, 2016 | Mar 31, 2016 |
| 10-K | Annual report | Jun 15, 2015 | Mar 31, 2015 |
| 10-K | Annual report | Jun 30, 2014 | Mar 31, 2014 |
| 10-K | Annual report | Jun 21, 2013 | Mar 31, 2013 |
| 10-K/A | Amended annual report | Sep 14, 2012 | Mar 31, 2012 |
| 10-K | Annual report | Jun 29, 2012 | Mar 31, 2012 |
| 10-K | Annual report | Jun 29, 2011 | Mar 31, 2011 |
| 10-K | Annual report | Jul 7, 2010 | Mar 31, 2010 |
| 10-K | Annual report | Jun 29, 2009 | Mar 31, 2009 |
| 10-K/A | Amended annual report | Jan 16, 2009 | Mar 31, 2008 |
| 10-K | Annual report | Jun 27, 2008 | Mar 31, 2008 |
| 10-K | Annual report | Jun 28, 2007 | Mar 31, 2007 |
| 10-K | Annual report | Jun 29, 2006 | Mar 31, 2006 |
| 10-K | Annual report | Jun 29, 2005 | Mar 31, 2005 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTP (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NJ
- Headquarters
- Northvale, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1053369
- Former names
- ELITE PHARMACEUTICALS INC /DE/ (until Feb 8, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.